Australia Stock Exchange release from PHARMAUST : Appendix 4D & Half Year Report
18/02/2022 06:54
Australia Stock Exchange release from PHARMAUST PAA.AX : Appendix 4D & Half Year Report
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility